Therapy for hepatocyte transporter trafficking mutations: The time is now

被引：2

作者：

Ananthanarayanan, Meenakshisundaram ^{[1
]}

机构：

[1] CUNY, Mt Sinai Med Ctr, Dept Pediat, Lab Dev & Mol Hepatol, New York, NY 10029 USA

来源：

HEPATOLOGY | 2007年 / 45卷 / 06期

关键词：

D O I：

10.1002/hep.21780

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1340 / 1342

页数：3

共 15 条

[1] Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration [J].

Geier, Andreas ;

Wagner, Martin ;

Dietrich, Christoph G. ;

Trauner, Michael .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2007, 1773 (03) :283-308

[2] The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver [J].

Gerloff, T ;

Stieger, B ;

Hagenbuch, B ;

Madon, J ;

Landmann, L ;

Roth, J ;

Hofmann, AF ;

Meier, PJ .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) :10046-10050

[3] Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome [J].

Hashimoto, K ;

Uchiumi, T ;

Konno, T ;

Ebihara, T ;

Nakamura, T ;

Wada, M ;

Sakisaka, S ;

Maniwa, F ;

Amachi, T ;

Ueda, K ;

Kuwano, M .

HEPATOLOGY, 2002, 36 (05) :1236-1245

[4] Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11 [J].

Hayashi, H ;

Takada, T ;

Suzuki, H ;

Akita, H ;

Sugiyama, Y .

HEPATOLOGY, 2005, 41 (04) :916-924

[5] Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome [J].

Keitel, V ;

Kartenbeck, J ;

Nies, AT ;

Spring, H ;

Brom, M ;

Keppler, D .

HEPATOLOGY, 2000, 32 (06) :1317-1328

[6] Intracellular trafficking and regulation of canalicular ATP-binding cassette transporters [J].

Kipp, H ;

Arias, IM .

SEMINARS IN LIVER DISEASE, 2000, 20 (03) :339-351

[7] Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury [J].

Lang, Carmen ;

Meier, Yvonne ;

Stieger, Bruno ;

Beuers, Ulrich ;

Lang, Thomas ;

Kerb, Reinhold ;

Kullak-Ublick, Gerd A. ;

Meier, Peter J. ;

Pauli-Magnus, Christiane .

PHARMACOGENETICS AND GENOMICS, 2007, 17 (01) :47-60

[8] THE CYSTIC-FIBROSIS MUTATION (DELTA-F508) DOES NOT INFLUENCE THE CHLORIDE CHANNEL ACTIVITY OF CFTR [J].

LI, CH ;

RAMJEESINGH, M ;

REYES, E ;

JENSEN, T ;

CHANG, XB ;

ROMMENS, JM ;

BEAR, CE .

NATURE GENETICS, 1993, 3 (04) :311-316

[9] A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperature-sensitive bile salt export pump [J].

Plass, JRM ;

Mol, O ;

Heegsma, J ;

Geuken, M ;

de Bruin, J ;

Elling, G ;

Müller, M ;

Faber, KN ;

Jansen, PLM .

JOURNAL OF HEPATOLOGY, 2004, 40 (01) :24-30

[10] A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in ΔF508-homozygous cystic fibrosis patients -: Partial restoration of nasal epithelial CFTR function [J].

Rubenstein, RC ;

Zeitlin, PL .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (02) :484-490

← 1 2 →